Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,391,802
+$144,537 QoQ
Shares Held
6,605
+3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,176
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KINTRA WEALTH, LLC holds $28,644,092 across 11 Drug Manufacturers - General names. AMGN ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,918 | $8,360,184 | |
| 2 | ABBV |
AbbVie Inc.
|
20,908 | $5,261,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
37,050 | $4,760,925 | |
| 4 | LLY |
ELI LILLY & Co
|
3,108 | $3,727,828 | |
| 5 | AMGN |
Amgen Inc
This page
|
6,605 | $2,391,802 | |
| 6 | PFE |
Pfizer Inc
|
56,271 | $1,355,005 | |
| 7 | NVS |
Novartis AG
|
5,118 | $802,092 | |
| 8 | NVO |
Novo Nordisk A S
|
14,248 | $683,049 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,391,802 | 6,605 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,247,265 | 6,387 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $325,346 | 994 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $229,428 | 813 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $255,477 | 915 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $207,492 | 666 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||